Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen D Ryder

Showing results (11-20 of 74) with videos related to

Pageof 8
Sort By:
European Journal of Gastroenterology & Hepatology|June 18, 2003
Magnetic resonance cholangiopancreatography versus endoscopic retrograde cholangiopancreatography in the diagnosis of choledocholithiasisNyree Griffin, Martin L Wastle, William K Dunn, et al.
International Journal of Hepatology|September 19, 2012
The utility of scoring systems in predicting early and late mortality in alcoholic hepatitis: whose score is it anyway?Naaventhan Palaniyappan, Venkataraman Subramanian, Vidyasagar Ramappa, et al.
The American Journal of Gastroenterology|September 14, 2021
Targeted Albumin Therapy Does Not Improve Short-Term Outcome in Hyponatremic Patients Hospitalized With Complications of Cirrhosis: Data From the ATTIRE TrialLouise China, Nick Freemantle, Ewan Forrest, et al.
Immunology Letters|December 13, 2006
Mannan binding lectin and viral hepatitisKristelle S Brown, Stephen D Ryder, William L Irving, et al.
Alcohol and Alcoholism (Oxford, Oxfordshire)|August 23, 2021
The Effect of Covid-19 on Alcohol Use Disorder and the Role of Universal Alcohol Screening in an Inpatient Setting: A Retrospective Cohort Control StudyMohsan Subhani, Abhishek Sheth, Stuart Unitt, et al.
Journal of Hepatocellular Carcinoma|October 31, 2017
Healthcare costs of transarterial chemoembolization in the treatment of hepatocellular carcinomaWaleed Fateen, Farooq Khan, Richard J O'Neill, et al.
Frontline Gastroenterology|August 26, 2017
Getting involved in clinical trials research in the UK: how can Clinical Research Networks help?Mark A Hull, Yan Yiannakou, Jonathan Gower, et al.
Eclinicalmedicine|November 21, 2022
Use of non-selective B-blockers is safe in hospitalised decompensated cirrhosis patients and exerts a potential anti-inflammatory effect: Data from the ATTIRE trialThais Tittanegro, Louise China, Ewan Forrest, et al.
Journal of Clinical Pathology|September 8, 2010
Portal inflammation is associated with advanced histological changes in alcoholic and non-alcoholic fatty liver diseaseEmad A Rakha, Louise Adamson, Emily Bell, et al.
Journal of Hepatology|October 7, 2004
Association of non-alcoholic steatohepatitis without significant fibrosis with hepatocellular carcinomaRachel E Bullock, Abed M Zaitoun, Guruprasad P Aithal, et al.
Pageof 8

Showing results (11-20 of 74) with videos related to

Sort By:
Pageof 8
European Journal of Gastroenterology & Hepatology|June 18, 2003
Magnetic resonance cholangiopancreatography versus endoscopic retrograde cholangiopancreatography in the diagnosis of choledocholithiasisNyree Griffin, Martin L Wastle, William K Dunn, et al.
International Journal of Hepatology|September 19, 2012
The utility of scoring systems in predicting early and late mortality in alcoholic hepatitis: whose score is it anyway?Naaventhan Palaniyappan, Venkataraman Subramanian, Vidyasagar Ramappa, et al.
The American Journal of Gastroenterology|September 14, 2021
Targeted Albumin Therapy Does Not Improve Short-Term Outcome in Hyponatremic Patients Hospitalized With Complications of Cirrhosis: Data From the ATTIRE TrialLouise China, Nick Freemantle, Ewan Forrest, et al.
Immunology Letters|December 13, 2006
Mannan binding lectin and viral hepatitisKristelle S Brown, Stephen D Ryder, William L Irving, et al.
Alcohol and Alcoholism (Oxford, Oxfordshire)|August 23, 2021
The Effect of Covid-19 on Alcohol Use Disorder and the Role of Universal Alcohol Screening in an Inpatient Setting: A Retrospective Cohort Control StudyMohsan Subhani, Abhishek Sheth, Stuart Unitt, et al.
Journal of Hepatocellular Carcinoma|October 31, 2017
Healthcare costs of transarterial chemoembolization in the treatment of hepatocellular carcinomaWaleed Fateen, Farooq Khan, Richard J O'Neill, et al.
Frontline Gastroenterology|August 26, 2017
Getting involved in clinical trials research in the UK: how can Clinical Research Networks help?Mark A Hull, Yan Yiannakou, Jonathan Gower, et al.
Eclinicalmedicine|November 21, 2022
Use of non-selective B-blockers is safe in hospitalised decompensated cirrhosis patients and exerts a potential anti-inflammatory effect: Data from the ATTIRE trialThais Tittanegro, Louise China, Ewan Forrest, et al.
Journal of Clinical Pathology|September 8, 2010
Portal inflammation is associated with advanced histological changes in alcoholic and non-alcoholic fatty liver diseaseEmad A Rakha, Louise Adamson, Emily Bell, et al.
Journal of Hepatology|October 7, 2004
Association of non-alcoholic steatohepatitis without significant fibrosis with hepatocellular carcinomaRachel E Bullock, Abed M Zaitoun, Guruprasad P Aithal, et al.
Pageof 8